2022 SCOA Annual Meeting Sponsors

Corporate Partner:
​Sharecare Health Data Services provides secure electronic exchange, delivery and integration of protected health information, with the latest compliance standards and unmatched multi-step quality control processes. Sharecare Health Data Services delivers a variety release of information, electronic health record, disability and FMLA form processing, and billing office workflow services.

Silver Sponsors: ​

Infinx provides innovative and scalable patient access and revenue cycle management lifecycle solutions for orthopedic practices. Combining an intelligent, cloud-based platform driven by artificial intelligence and automation, with our trained and certified prior authorization, coding and billing specialists, we help clients realize revenue, enabling them to shift focus from administrative details to billable patient care. Visit www.infinx.com for more information.

Bronze Sponsors: ​

Cerapedics is an advanced orthobiologics company with i-FACTOR® Peptide Enhanced Bone Graft (P-15/ABM) which is only the second FDA PMA approved bone graft on the market, and its novel mechanism of action (Attract, Attach, Activate) has shown to be statistically superior to local autograft through an IDE trial on single-level ACDFs in overall clinical success at one year and maintained at two years.
Copper Sponsors: 
SI-BONE, Inc. is a leading medical device company that has developed the iFuse Implant System®, a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint. The iFuse Implant, available since 2009, is the only device for treatment of SI joint dysfunction supported by significant published clinical evidence, including level 1 trials, showing safety, effectiveness and durability, including lasting pain relief.
Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions. The company markets MACI® (autologous cultured chondrocytes on porcine collagen membrane), a third generation autologous cellularized scaffold product that is indicated for the repair of single or multiple symptomatic, full-thickness cartilage defects of the adult knee, with or without bone involvement.